Flow cytometry reveals TEK expression in:
Notably absent in mature erythroid/myeloid lineages .
In clear cell renal cell carcinoma (ccRCC):
Cohort | TEK Downregulation Impact | Statistical Significance |
---|---|---|
TCGA (n=537) | Reduced 5-year survival | p<0.0001 |
ICGC (n=327) | Shorter progression-free survival | p=0.0044 |
Multivariate analysis confirms TEK as independent prognostic factor (HR=2.14, p<0.001) .
12 novel heterozygous TEK mutations identified in primary congenital glaucoma :
Mutation | Protein Change | Allele Frequency (PCG) | ExAC Frequency | Pathogenicity Score |
---|---|---|---|---|
g.48947A>C | p.E103D | 0.89% | 0.0008978 | 0.26/0.996/45 |
g.48993C>T | p.R119C | 0.14% | 0.00001648 | 0.08/0.997/180 |
Mutations affect conserved residues in immunoglobulin-like domains .
Virtual screening identified novel TEK inhibitors with promising activity :
Compound | Strategy | IC50 (μM) | Target Engagement |
---|---|---|---|
TP-C1-17 | 1 | 9.2 | ATP-binding pocket |
TP-C2-08 | 2 | 4.7 | Hydrophobic cleft |
TP-C2-13 | 2 | 3.1 | DFG motif |
Strategy 2 (top-200 compounds + strict drug-likeness filters) yielded 4.6× more hits <10 μM IC50 than Strategy 1 .
Key molecular partners:
TIE-1 and TIE-2/Tek are receptor tyrosine kinases (RTKs) primarily found on endothelial and hematopoietic progenitor cells. They play crucial roles in angiogenesis, vasculogenesis, and hematopoiesis. TIE-1 is a 1122 amino acid protein with unique structural characteristics, including immunoglobulin-like and epidermal growth factor (EGF)-like domains. TIE-2 binds to angiopoietin-1 (Ang1) and angiopoietin-2 (Ang2), with Ang2 potentially acting as an antagonist to Ang1. Disruptions in these pathways, such as Ang2 overexpression or Ang1/Tie-1 deficiency, can lead to angiogenic defects.
Recombinant human TEK, expressed in Sf9 insect cells using baculovirus, is a glycosylated polypeptide chain with a molecular weight of approximately 107.9 kDa (appears as 100-150 kDa on SDS-PAGE). It encompasses amino acids 23-748 of the TEK protein and includes a C-terminal 239 amino acid hIgG-His tag for purification.
The TEK protein is supplied in a solution at a concentration of 0.5 mg/ml, containing 10% glycerol and Phosphate Buffered Saline (pH 7.4).
For short-term storage (up to 4 weeks), store the protein solution at 4°C. For extended storage, freeze the solution at -20°C. To ensure stability during long-term storage, consider adding a carrier protein like HSA or BSA (0.1%). Avoid repeated freeze-thaw cycles to maintain protein integrity.
The purity of the TEK protein is greater than 90% as determined by SDS-PAGE analysis.
The biological activity of TEK is determined by its binding ability in a functional ELISA. The ED50 value is less than or equal to 1 µg/ml, indicating its potency in this assay.
TEK Receptor Tyrosine Kinase, Tyrosine Kinase With Ig And EGF Homology Domains-2, Tunica Interna Endothelial Cell Kinase, Tyrosine-Protein Kinase Receptor TIE-2, Tyrosine-Protein Kinase Receptor TEK, TEK Tyrosine Kinase, Endothelial, Endothelial Tyrosine Kinase, EC 2.7.10.1, VMCM1, VMCM, TIE2, Venous Malformations, Multiple Cutaneous And Mucosal, Angiopoietin-1 Receptor, CD202b Antigen, EC 2.7.10, P140 TEK, CD202B, GLC3E, TIE-2, HTIE2.
AMDLILINSL PLVSDAETSL TCIASGWRPH EPITIGRDFE ALMNQHQDPL EVTQDVTREW AKKVVWKREK ASKINGAYFC EGRVRGEAIR IRTMKMRQQA SFLPATLTMT VDKGDNVNIS FKKVLIKEED AVIYKNGSFI HSVPRHEVPD ILEVHLPHAQ PQDAGVYSAR YIGGNLFTSA FTRLIVRRCE AQKWGPECNH LCTACMNNGV CHEDTGECIC PPGFMGRTCE KACELHTFGR TCKERCSGQE GCKSYVFCLP DPYGCSCATG WKGLQCNEAC HPGFYGPDCK LRCSCNNGEM CDRFQGCLCS PGWQGLQCER EGIPRMTPKI VDLPDHIEVN SGKFNPICKA SGWPLPTNEE MTLVKPDGTV LHPKDFNHTD HFSVAIFTIH RILPPDSGVW VCSVNTVAGM VEKPFNISVK VLPKPLNAPN VIDTGHNFAV INISSEPYFG DGPIKSKKLL YKPVNHYEAW QHIQVTNEIV TLNYLEPRTE YELCVQLVRR GEGGEGHPGP VRRFTTASIG LPPPRGLNLL PKSQTTLNLT WQPIFPSSED DFYVEVERRS VQKSDQQNIK VPGNLTSVLL NNLHPREQYV VRARVNTKAQ GEWSEDLTAW TLSDILPPQP ENIKISNITH SSAVISWTIL DGYSISSITI RYKVQGKNED QHVDVKIKNA TITQYQLKGL EPETAYQVDI FAENNIGSSN PAFSHELVTL PESQAPADLG GGKMLLLEPK SCDKTHTCPP CPAPELLGGP SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSRDEL TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ QGNVFSCSVM HEALHNHYTQ KSLSLSPGKH HHHHH.
TEK, also known as TIE-2, is a receptor tyrosine kinase (RTK) that functions primarily in vascular endothelial cells. It forms a subfamily of RTK together with TIE, and these two receptors collaborate to play critical roles in vascular maturation, maintenance of integrity, and remodeling . Beyond vascular systems, TEK demonstrates expression in human hematopoietic cells, suggesting more diverse biological functions than initially understood. The biological significance of TEK extends to its involvement in hematopoietic cell-microenvironment interactions, making it a critical molecule for both vascular biology and hematopoietic research . Understanding TEK's dual role provides valuable insights into the interconnected nature of vascular and hematopoietic systems in human biology.
TEK expression in human hematopoietic cells follows a specific pattern that suggests its importance in early hematopoietic development. Flow cytometric analysis of bone marrow cells has revealed that TEK is expressed in approximately 27% of CD34+ cells, 20% of c-KIT+ cells, and 26% of CD34+CD38- cells, indicating its presence in a subset of primitive hematopoietic stem cells (HSCs) . Additionally, TEK is expressed in 20% of CD19+ B lymphocytes but not in other lineage-committed cells. This selective expression pattern provides valuable markers for identifying specific hematopoietic subpopulations with potential functional significance.
Methodologically, researchers exploring TEK expression should employ monoclonal antibodies against the extracellular domain of human TEK protein for optimal detection in flow cytometric analysis. This approach offers high specificity and sensitivity for characterizing TEK-positive cell populations in complex biological samples.
TEK-expressing hematopoietic cells demonstrate distinct functional properties that differentiate them from TEK-negative populations. Progenitor assays in methylcellulose culture have shown that CD34+TEK+ cells form significantly fewer burst-forming unit-erythroid (BFU-E) and colony-forming unit-mix (CFU-Mix) than CD34+TEK- cells . Interestingly, there is no significant difference in the number of colony-forming unit-granulocyte/macrophage (CFU-GM) between these two populations. This functional divergence suggests that TEK expression correlates with specific differentiation potentials within the hematopoietic hierarchy.
From a methodological perspective, researchers should implement standardized methylcellulose culture conditions when comparing TEK-positive and TEK-negative populations to ensure reliable and reproducible results. Careful isolation of these populations using fluorescence-activated cell sorting (FACS) based on TEK expression provides the foundation for subsequent functional characterization.
The primary ligands for TEK are Angiopoietin-1 and Angiopoietin-2, which bind to the receptor with similar affinities but elicit different biological responses . Angiopoietin-1 effectively induces TEK phosphorylation in hematopoietic cells, suggesting active signaling induction. In contrast, Angiopoietin-2 induces a lower level of TEK phosphorylation and can actually weaken the phosphorylation induced by Angiopoietin-1, functioning as an elaborate regulator of the TEK-TEK ligand signaling pathway .
This regulatory mechanism presents a sophisticated model where Angiopoietin-2 serves as a partial antagonist to Angiopoietin-1, fine-tuning TEK signaling in response to environmental conditions. This complex interplay between angiopoietins creates a nuanced signaling environment that may allow for precise regulation of TEK-dependent cellular functions.
The methodological implication is that researchers studying TEK's role in hematopoietic cell-microenvironment interactions should focus on adhesion assays rather than proliferation assays to detect significant effects. Cell adhesion experiments using purified extracellular matrix components and primary stromal cells provide valuable insights into the specific mechanisms through which TEK signaling mediates these interactions.
Addressing contradictions in TEK research data requires systematic methodological approaches. When conflicting results emerge regarding TEK expression or function, researchers should implement both unstructured and structured approaches to identify the source of discrepancies . In the unstructured approach, a transformation model directly processes all data for prediction. The structured approach involves pairing data points separately before analysis, explicitly accounting for natural experimental structure .
Research has shown that structured approaches for contradiction detection are more robust in analysis and more transferable to out-of-distribution scenarios than unstructured approaches . This finding challenges the mainstream unstructured approach of simply applying pre-trained models and expecting them to learn the structure, particularly for scenarios where intermediate in-domain data are scarce. For TEK research specifically, this suggests adopting structured analytical frameworks when comparing results across different experimental systems or cell types.
Effective experimental design for TEK human research should follow a structured four-stage process:
Hypothesis Formation: Establish a clear, testable hypothesis regarding TEK function, expression, or signaling .
Treatment Levels and Variables: Define the independent variable to be manipulated (e.g., angiopoietin concentration), the dependent variable to be measured (e.g., TEK phosphorylation level), and control for extraneous conditions .
Sampling Methodology: Establish rigorous protocols for cell isolation and characterization.
Data Analysis Framework: Determine appropriate statistical tests for comparing TEK-positive and TEK-negative populations.
The main objective of experimental design in TEK research should be to establish the effect that an independent variable has on a dependent variable . For example, when investigating how Angiopoietin-1 affects TEK phosphorylation, the independent variable is Angiopoietin-1 concentration, while the dependent variable is TEK phosphorylation level. When applied correctly, this experimental design framework enables researchers to establish causal relationships between variables with greater confidence.
Tables serve three primary functions in TEK research: they help organize and condense data, allow analysis from various perspectives, and display evidence succinctly and convincingly . Different table types serve specific research needs in TEK studies:
Table Type | Function | Application in TEK Research | Example Format |
---|---|---|---|
Data Sources | Documents data sources used | Cataloging antibodies, cell lines, primary samples | List of sources with descriptions and quantities |
Data Analysis | Lists analytical steps | Detailing flow cytometry gating strategy or Western blot protocols | Chronological steps with examples |
Concept-Evidence | Links concepts with evidence | Correlating TEK expression with functional outcomes | Concepts with supporting experimental evidence |
Cross-Case Analysis | Compares findings across cases | Comparing TEK expression across different hematopoietic disorders | Cases with comparative evidence |
Temporally Ordered | Tracks changes over time | Following TEK phosphorylation kinetics after ligand binding | Time points with corresponding measurements |
Researchers should select table types that best communicate their specific research objectives and findings . For TEK expression studies, concept-evidence tables that correlate expression levels with functional outcomes are particularly valuable. For signaling studies, temporally ordered tables that track phosphorylation events over time provide clear visualization of kinetic relationships.
Detecting and addressing contradictions in TEK research data requires methodological rigor. Two primary approaches have been validated for contradiction detection:
Unstructured Approach: A Transformer model directly processes the concatenation of all experimental data for prediction, following standard analysis paradigms .
Structured Approach: Data points are paired separately before analysis, explicitly accounting for the natural experimental structure .
Research has demonstrated that the structured approach for contradiction detection is more robust and more transferable to out-of-distribution scenarios than the unstructured approach . For TEK researchers, this means that explicitly considering the relationship between experimental conditions and outcomes, rather than treating all data as an undifferentiated whole, leads to more reliable detection of contradictions.
When contradictions are identified, researchers should implement systematic resolution strategies, including:
Experimental repetition with standardized protocols
Cross-validation using alternative methodologies
Independent verification by separate research groups
Meta-analysis of all available data to identify patterns in contradictory results
The TEK receptor tyrosine kinase is a cell-surface receptor that binds to angiopoietins, specifically ANGPT1, ANGPT2, and ANGPT4 . The receptor has a unique extracellular region that includes:
Upon binding to its ligands, TEK activates a signaling pathway that is essential for various cellular processes, including:
Recombinant TEK protein is produced using various expression systems, including human cells and Sf9 Baculovirus cells . The recombinant protein is often tagged with markers such as DDK/His for purification and identification purposes . It is used in research to study its function and role in angiogenesis and related processes.
The recombinant TEK protein is a valuable tool in biomedical research. It is used to: